Craig V Comiter, MD
Urology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 4 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
15 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Comiter’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G84429 · Current
Licensed to practise in California · since 2007 · expires 2027-09-30 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$163,102
Medicare paid this office $163,102 for 774 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 316 | $31,053 | $98 |
| Waterjet destruction of prostrate accessed through the urethra | 32 | $20,798 | $650 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 68 | $11,407 | $131 |
| Insertion of inflatable urethra or bladder neck sphincter | 16 | $10,663 | $666 |
| Complete laser vaporization of prostate including control of bleeding using an endoscope | 12 | $7,278 | $606 |
See all 22 services
| New patient visit (45+ min) | 316 | $31,053 | $98 |
| Waterjet destruction of prostrate accessed through the urethra | 32 | $20,798 | $650 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 68 | $11,407 | $131 |
| Insertion of inflatable urethra or bladder neck sphincter | 16 | $10,663 | $666 |
| Complete laser vaporization of prostate including control of bleeding using an endoscope | 12 | $7,278 | $606 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 11 | $7,067 | $642 |
| Diagnostic exam of bladder and urethra using an endoscope | 103 | $6,561 | $62 |
| Return visit (30+ min) | 77 | $6,460 | $81 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 70 | $5,588 | $80 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 40 | $3,412 | $85 |
| Insertion of device into abdomen with pressure and urine flow rate study | 108 | $3,327 | $31 |
| Short return visit (20+ min) | 59 | $2,916 | $48 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 50 | $2,470 | $40 |
| New patient visit (45+ min) | 19 | $2,246 | $118 |
| Return visit (30+ min) | 20 | $2,038 | $97 |
| New patient visit (60+ min) | 11 | $1,632 | $148 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 108 | $1,571 | $15 |
| Injection procedure for imaging of bladder during voiding | 78 | $1,515 | $19 |
| Short return visit (20+ min) | 19 | $1,383 | $73 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 89 | $1,111 | $12 |
| Review by radiologist of urinary bladder image | 66 | $893 | $14 |
| Electronic assessment of bladder emptying | 120 | $599 | $5 |
Procedures Medicare counted
| Prostate resection | 46 | More than 96% of doctors who do this |
Who their Medicare patients are
774 Original Medicare patients in 2024. Average age 75 · Under 65 7% · 85 and older 13% · Women 28% · Also on Medicaid 20% · Health risk score 1.39. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 70% · Coronary heart disease 31% · Diabetes 25% · Chronic kidney disease 25% · Cancer 24% · Atrial fibrillation 21% · Heart failure 17% · Depression 17% · COPD 11% · Dementia 8% · Stroke 8%.
The office billed $1,638,713, Medicare allowed $224,614 and paid $163,102; for 1,671 services of 80 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 774 | 1,671 | 75 | 1.39 | $1,638,713 | $163,102 |
| 2023 | 919 | 1,850 | 74 | 1.47 | $1,563,202 | $197,439 |
| 2022 | 906 | 2,120 | 74 | 1.42 | $1,726,630 | $207,835 |
| 2021 | 827 | 2,010 | 74 | 1.51 | $1,407,571 | $184,464 |
| 2020 | 794 | 1,969 | 73 | 1.62 | $1,593,093 | $186,019 |
| 2019 | 731 | 1,768 | 74 | 1.48 | $1,136,004 | $170,913 |
| 2018 | 831 | 2,238 | 73 | 1.63 | $1,729,286 | $218,232 |
| 2017 | 823 | 2,267 | 73 | 1.56 | $1,807,111 | $218,096 |
| 2016 | 769 | 2,015 | 73 | 1.41 | $1,601,653 | $204,687 |
| 2015 | 774 | 2,266 | 73 | 1.46 | $1,485,442 | $211,523 |
| 2014 | 755 | 2,390 | 72 | 1.42 | $1,592,298 | $228,869 |
| 2013 | 614 | 2,009 | 72 | 1.47 | $1,427,514 | $194,285 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| New patient visit (45+ min) | 315 | $34,061 | $108 |
| Waterjet destruction of prostrate accessed through the urethra | 32 | $20,978 | $656 |
| Insertion of inflatable urethra or bladder neck sphincter | 18 | $11,394 | $633 |
| Return visit (30+ min) | 145 | $11,208 | $76 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 74 | $11,031 | $114 |
| Diagnostic exam of bladder and urethra using an endoscope | 99 | $6,853 | $67 |
| New patient visit (45+ min) | 55 | $5,883 | $107 |
| Short return visit (20+ min) | 90 | $4,892 | $52 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 45 | $4,462 | $99 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 50 | $4,355 | $87 |
| Long return visit (40+ min) | 30 | $3,735 | $124 |
| Insertion of device into abdomen with pressure and urine flow rate study | 91 | $3,119 | $34 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 45 | $2,258 | $44 |
| Return visit (30+ min) | 24 | $2,028 | $81 |
| Dilation of urethra using an endoscope | 15 | $2,021 | $119 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 95 | $1,509 | $16 |
| New patient visit (30+ min) | 14 | $1,060 | $76 |
| Injection procedure for imaging of bladder during voiding | 55 | $998 | $18 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 68 | $976 | $14 |
| Review by radiologist of urinary bladder image | 55 | $768 | $14 |
| Electronic assessment of bladder emptying | 135 | $726 | $5 |
| Electronic assessment of bladder emptying | 11 | $55 | $5 |
2022: 23 services
| Waterjet destruction of prostrate accessed through the urethra | 54 | $36,296 | $672 |
| New patient visit (45+ min) | 288 | $31,460 | $109 |
| Return visit (30+ min) | 149 | $13,133 | $82 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 67 | $9,721 | $94 |
| New patient visit (45+ min) | 85 | $9,000 | $106 |
| Insertion of inflatable urethra or bladder neck sphincter | 14 | $8,893 | $635 |
| Diagnostic exam of bladder and urethra using an endoscope | 100 | $6,784 | $66 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 73 | $6,279 | $86 |
| Short return visit (20+ min) | 93 | $5,284 | $53 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 53 | $5,240 | $99 |
| Insertion of device into abdomen with pressure and urine flow rate study | 124 | $4,133 | $33 |
| Long return visit (40+ min) | 28 | $3,627 | $130 |
| Injection procedure for imaging of bladder during voiding | 111 | $2,035 | $18 |
| New patient visit (60+ min) | 13 | $2,012 | $155 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 123 | $1,917 | $16 |
| Return visit (30+ min) | 22 | $1,810 | $79 |
| New patient visit (30+ min) | 23 | $1,599 | $70 |
| Review by radiologist of urinary bladder image | 105 | $1,456 | $14 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 104 | $1,432 | $14 |
| Dilation of urethra using an endoscope | 11 | $1,308 | $119 |
| Electronic assessment of bladder emptying | 139 | $741 | $5 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $521 | $35 |
| Simple bladder irrigation and/or instillation | 16 | $382 | $22 |
2021: 27 services
| New patient visit (45+ min) | 221 | $26,377 | $119 |
| Return visit (30+ min) | 107 | $9,953 | $87 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 15 | $9,771 | $651 |
| Short return visit (20+ min) | 129 | $8,156 | $55 |
| New patient visit (45+ min) | 67 | $7,953 | $119 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 65 | $7,854 | $93 |
| Creation of sling around urethra in female to control leakage | 12 | $7,590 | $633 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 68 | $7,538 | $111 |
| Insertion of sacral nerve neurostimulator electrode | 12 | $7,329 | $611 |
| Diagnostic exam of bladder and urethra using an endoscope | 92 | $6,595 | $69 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 51 | $4,393 | $86 |
| Insertion of device into abdomen with pressure and urine flow rate study | 118 | $4,080 | $35 |
| Long return visit (40+ min) | 24 | $2,933 | $122 |
| New patient visit (30+ min) | 33 | $2,476 | $75 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 118 | $1,918 | $16 |
| Injection procedure for imaging of bladder during voiding | 101 | $1,877 | $19 |
| Review by radiologist of urinary bladder image | 110 | $1,560 | $14 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 107 | $1,560 | $15 |
| New patient visit (30+ min) | 19 | $1,361 | $72 |
| Diagnostic exam of bladder and urethra using an endoscope | 19 | $1,301 | $68 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 11 | $1,250 | $114 |
| Return visit (30+ min) | 13 | $1,075 | $77 |
| Electronic assessment of bladder emptying | 124 | $666 | $5 |
| Simple bladder irrigation and/or instillation | 20 | $486 | $24 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $391 | $36 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 11 | $185 | $17 |
| Electronic assessment of bladder emptying | 17 | $100 | $6 |
2020: 26 services
| New patient visit (45+ min) | 275 | $28,605 | $104 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 19 | $13,149 | $692 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 15 | $11,718 | $781 |
| Short return visit (20+ min) | 184 | $8,889 | $42 |
| Diagnostic exam of bladder and urethra using an endoscope | 130 | $8,705 | $66 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 74 | $8,117 | $108 |
| Insertion of inflatable urethra or bladder neck sphincter | 11 | $7,570 | $688 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 70 | $7,344 | $80 |
| Insertion of sacral nerve neurostimulator electrode | 11 | $6,671 | $606 |
| Insertion of device into abdomen with pressure and urine flow rate study | 117 | $4,223 | $35 |
| New patient visit (60+ min) | 25 | $3,664 | $147 |
| Return visit (30+ min) | 51 | $3,466 | $65 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 45 | $3,429 | $76 |
| New patient visit (45+ min) | 26 | $3,002 | $115 |
| New patient visit (30+ min) | 37 | $2,384 | $64 |
| Insertion of stent in ureter using an endoscope | 14 | $2,339 | $167 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 11 | $1,787 | $149 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 108 | $1,744 | $16 |
| Long return visit (40+ min) | 19 | $1,668 | $88 |
| Dilation of urethra using an endoscope | 12 | $1,637 | $136 |
| Review by radiologist of urinary bladder image | 107 | $1,596 | $15 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 100 | $1,551 | $15 |
| Injection procedure for imaging of bladder during voiding | 71 | $1,238 | $17 |
| Short return visit (20+ min) | 15 | $700 | $47 |
| Simple bladder irrigation and/or instillation | 26 | $683 | $25 |
| Electronic assessment of bladder emptying | 120 | $658 | $5 |
2019: 22 services
| New patient visit (45+ min) | 289 | $31,351 | $108 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 18 | $12,175 | $676 |
| Insertion of inflatable urethra or bladder neck sphincter | 14 | $10,431 | $695 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 66 | $9,462 | $105 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 76 | $8,460 | $111 |
| Diagnostic exam of bladder and urethra using an endoscope | 113 | $7,999 | $67 |
| Short return visit (20+ min) | 137 | $6,384 | $42 |
| Insertion of device into abdomen with pressure and urine flow rate study | 111 | $4,050 | $36 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 40 | $3,686 | $92 |
| New patient visit (30+ min) | 50 | $3,109 | $62 |
| Dilation of bladder using an endoscope under general or spinal anesthesia | 12 | $2,428 | $187 |
| Long return visit (40+ min) | 23 | $2,310 | $100 |
| Injection procedure for imaging of bladder during voiding | 108 | $2,143 | $20 |
| Return visit (30+ min) | 28 | $2,081 | $69 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 111 | $1,878 | $17 |
| New patient visit (60+ min) | 13 | $1,686 | $130 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 110 | $1,658 | $15 |
| Dilation of urethra using an endoscope | 11 | $1,419 | $118 |
| Review by radiologist of urinary bladder image | 45 | $667 | $15 |
| Electronic assessment of bladder emptying | 118 | $610 | $5 |
| Simple bladder irrigation and/or instillation | 16 | $329 | $19 |
| Imaging guidance for procedure, 60 minutes or less | 11 | $153 | $14 |
2018: 27 services
| New patient visit (45+ min) | 323 | $35,179 | $109 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 41 | $26,764 | $653 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 84 | $14,313 | $131 |
| Insertion of inflatable urethra or bladder neck sphincter | 16 | $11,683 | $687 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 88 | $9,196 | $105 |
| Insertion of sacral nerve neurostimulator electrode | 14 | $8,405 | $600 |
| Removal and replacement of inflatable urethra or bladder neck sphincter | 12 | $8,181 | $682 |
| Diagnostic exam of bladder and urethra using an endoscope | 118 | $7,926 | $65 |
| Creation of sling around urethra in female to control leakage | 13 | $7,787 | $599 |
| New patient visit (30+ min) | 98 | $6,050 | $62 |
| Short return visit (20+ min) | 126 | $5,563 | $38 |
| Insertion of device into abdomen with pressure and urine flow rate study | 132 | $4,733 | $36 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 49 | $4,144 | $85 |
| Return visit (30+ min) | 47 | $3,149 | $67 |
| Injection procedure for imaging of bladder during voiding | 136 | $2,573 | $19 |
| New patient visit (60+ min) | 18 | $2,566 | $143 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 150 | $2,436 | $16 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 15 | $2,049 | $137 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 136 | $2,031 | $15 |
| Dilation of urethra using an endoscope | 16 | $1,991 | $117 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 11 | $1,580 | $144 |
| Review by radiologist of urinary bladder image | 101 | $1,478 | $14 |
| Insertion of stent in ureter using an endoscope | 12 | $1,353 | $113 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 13 | $1,252 | $96 |
| Electronic assessment of bladder emptying | 172 | $853 | $5 |
| Simple bladder irrigation and/or instillation | 25 | $548 | $22 |
| Imaging guidance for procedure, 60 minutes or less | 14 | $108 | $8 |
2017: 24 services
| New patient visit (45+ min) | 325 | $33,440 | $103 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 80 | $14,821 | $140 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 17 | $13,086 | $770 |
| Diagnostic exam of bladder and urethra using an endoscope | 133 | $12,319 | $87 |
| Insertion of sacral nerve neurostimulator electrode | 16 | $10,173 | $598 |
| Insertion of inflatable urethra or bladder neck sphincter | 14 | $8,940 | $639 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 72 | $7,932 | $110 |
| New patient visit (30+ min) | 118 | $7,369 | $62 |
| Creation of sling around urethra in female to control leakage | 11 | $6,815 | $620 |
| Short return visit (20+ min) | 129 | $6,273 | $42 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 70 | $5,645 | $78 |
| Insertion of device into abdomen with pressure and urine flow rate study | 141 | $5,072 | $35 |
| Dilation of urethra using an endoscope | 22 | $3,267 | $131 |
| Return visit (30+ min) | 39 | $2,681 | $69 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 142 | $2,319 | $16 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 17 | $2,252 | $132 |
| New patient visit (60+ min) | 14 | $2,104 | $150 |
| Injection procedure for imaging of bladder during voiding | 107 | $2,088 | $19 |
| Review by radiologist of urinary bladder image | 138 | $2,019 | $14 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 133 | $1,994 | $15 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 13 | $1,943 | $149 |
| Electronic assessment of bladder emptying | 162 | $829 | $5 |
| Simple bladder irrigation and/or instillation | 18 | $459 | $24 |
| Imaging guidance for procedure, 60 minutes or less | 18 | $146 | $8 |
2016: 22 services
| New patient visit (45+ min) | 300 | $32,155 | $107 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 24 | $17,309 | $721 |
| Diagnostic exam of bladder and urethra using an endoscope | 134 | $14,852 | $105 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 64 | $12,532 | $141 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 102 | $10,238 | $99 |
| Insertion of sacral nerve neurostimulator electrode | 14 | $8,072 | $577 |
| Insertion of inflatable urethra or bladder neck sphincter | 12 | $7,878 | $657 |
| New patient visit (30+ min) | 120 | $7,085 | $59 |
| Insertion of device into abdomen with pressure and urine flow rate study | 149 | $5,408 | $36 |
| Short return visit (20+ min) | 120 | $5,224 | $41 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 135 | $4,524 | $33 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 50 | $4,172 | $83 |
| New patient visit (60+ min) | 21 | $2,884 | $137 |
| Dilation of urethra using an endoscope | 15 | $2,407 | $134 |
| Dilation of bladder using an endoscope under general or spinal anesthesia | 11 | $2,081 | $189 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 129 | $1,926 | $15 |
| Review by radiologist of urinary bladder image | 123 | $1,792 | $14 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 11 | $1,632 | $148 |
| Return visit (30+ min) | 23 | $1,569 | $68 |
| Electronic assessment of bladder emptying | 156 | $838 | $5 |
| Simple bladder irrigation and/or instillation | 26 | $641 | $25 |
| Imaging guidance for procedure, 60 minutes or less | 13 | $100 | $8 |
2015: 21 services
| New patient visit (45+ min) | 291 | $30,611 | $105 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 32 | $24,314 | $760 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 136 | $14,897 | $106 |
| Diagnostic exam of bladder and urethra using an endoscope | 113 | $12,415 | $105 |
| Short return visit (20+ min) | 205 | $9,832 | $41 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 56 | $9,624 | $139 |
| Insertion of sacral nerve neurostimulator electrode | 12 | $8,510 | $532 |
| Creation of sling around urethra in female to control leakage | 11 | $6,768 | $615 |
| Insertion of device into abdomen with pressure and urine flow rate study | 164 | $6,047 | $36 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 156 | $5,372 | $34 |
| New patient visit (30+ min) | 66 | $4,101 | $62 |
| Return visit (30+ min) | 50 | $3,367 | $66 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 34 | $2,627 | $77 |
| Simple bladder irrigation and/or instillation | 110 | $2,426 | $21 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 149 | $2,199 | $15 |
| New patient visit (60+ min) | 15 | $2,196 | $146 |
| Review by radiologist of urinary bladder image | 146 | $2,109 | $14 |
| Insertion of stent in ureter using an endoscope | 15 | $1,627 | $108 |
| Electronic assessment of bladder emptying | 172 | $868 | $5 |
| Electronic analysis of implanted neurostimulator generator with simple spinal cord or peripheral nerve stimulator programming | 14 | $471 | $34 |
| Imaging guidance for procedure, 60 minutes or less | 18 | $133 | $7 |
2014: 23 services
| New patient visit (45+ min) | 305 | $33,761 | $111 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 27 | $20,059 | $743 |
| Diagnostic exam of bladder and urethra using an endoscope | 125 | $13,343 | $103 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 117 | $12,356 | $106 |
| Creation of sling around urethra in female to control leakage | 20 | $11,606 | $580 |
| Insertion of inflatable urethra or bladder neck sphincter | 15 | $8,834 | $589 |
| Insertion of sacral nerve neurostimulator electrode | 13 | $8,316 | $594 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 53 | $8,084 | $142 |
| Short return visit (20+ min) | 169 | $7,686 | $40 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 176 | $6,211 | $35 |
| Insertion of device into abdomen with pressure and urine flow rate study | 172 | $6,202 | $36 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 60 | $5,168 | $86 |
| Return visit (30+ min) | 65 | $4,260 | $64 |
| New patient visit (60+ min) | 32 | $4,039 | $126 |
| Simple bladder irrigation and/or instillation | 176 | $3,535 | $20 |
| New patient visit (30+ min) | 40 | $2,565 | $64 |
| Review by radiologist of urinary bladder image | 174 | $2,438 | $14 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 164 | $2,418 | $15 |
| Injection of implant material beneath lining of bladder and/or urethra using an endoscope | 12 | $2,322 | $179 |
| Dilation of bladder using an endoscope under general or spinal anesthesia | 11 | $2,259 | $188 |
| Revision of peripheral neurostimulator electrodes | 20 | $2,257 | $113 |
| Electronic assessment of bladder emptying | 159 | $787 | $5 |
| Imaging guidance for procedure, 60 minutes or less | 18 | $136 | $8 |
2013: 19 services
| New patient visit (45+ min) | 210 | $21,899 | $104 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 28 | $20,464 | $731 |
| New patient visit (60+ min) | 73 | $10,346 | $142 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 99 | $10,038 | $100 |
| Insertion of sacral nerve neurostimulator electrode | 16 | $9,876 | $549 |
| Short return visit (20+ min) | 198 | $9,818 | $39 |
| Diagnostic exam of bladder and urethra using an endoscope | 71 | $8,009 | $105 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 41 | $6,551 | $134 |
| Insertion of device into abdomen with pressure and urine flow rate study | 138 | $4,720 | $34 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 135 | $4,511 | $33 |
| Return visit (30+ min) | 67 | $4,437 | $64 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 41 | $3,439 | $84 |
| Simple bladder irrigation and/or instillation | 137 | $2,625 | $19 |
| Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | 123 | $1,700 | $14 |
| Review by radiologist of urinary bladder image | 123 | $1,629 | $13 |
| Long return visit (40+ min) | 17 | $1,543 | $91 |
| Revision of peripheral neurostimulator electrodes | 13 | $1,511 | $108 |
| Electronic assessment of bladder emptying | 139 | $737 | $5 |
| Imaging guidance for procedure, 60 minutes or less | 19 | $143 | $8 |
Medicaid work
$41,027 in 2024
Medicaid paid $41,027 for 813 billed services this clinician did in 2024, up to 41 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 181 | $16,017 |
| Return visit (30+ min) | 172 | $13,077 |
| Long return visit (40+ min) | 27 | $3,525 |
| Service | 81 | $2,410 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 198 | $1,895 |
| Hospital outpatient clinic visit for assessment and management of a patient | 60 | $1,510 |
| New patient visit (30+ min) | 14 | $924 |
| Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming | 52 | $902 |
| Short return visit (20+ min) | 12 | $735 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 16 | $33 |
| 2024 | 813 | 10 | 41 | $41,027 |
| 2023 | 509 | 10 | 28 | $21,833 |
| 2022 | 427 | 6 | 24 | $15,772 |
| 2021 | 424 | 5 | 24 | $15,486 |
| 2020 | 200 | 4 | 22 | $6,158 |
| 2019 | 105 | 3 | 18 | $3,853 |
| 2018 | 124 | 3 | 21 | $2,101 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 154 | $8,935 |
| Return visit (30+ min) | 207 | $8,588 |
| Cystourethroscopy, with injection(s) for chemodenervation of the bladder | 12 | $1,093 |
| New patient visit (30+ min) | 12 | $880 |
| Long return visit (40+ min) | 14 | $694 |
| Short return visit (20+ min) | 30 | $675 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 43 | $365 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 13 | $305 |
| ANAL/URINARY MUSCLE STUDY | 12 | $161 |
| INTRAABDOMINAL PRESSURE TEST | 12 | $138 |
2022
| New patient visit (45+ min) | 142 | $7,808 |
| Return visit (30+ min) | 195 | $6,597 |
| Long return visit (40+ min) | 18 | $524 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 45 | $299 |
| Short return visit (20+ min) | 12 | $288 |
| Hospital outpatient clinic visit for assessment and management of a patient | 15 | $256 |
2021
| New patient visit (45+ min) | 121 | $7,261 |
| Return visit (30+ min) | 119 | $3,904 |
| Short return visit (20+ min) | 143 | $3,688 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 26 | $527 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 15 | $106 |
2020
| New patient visit (45+ min) | 59 | $3,147 |
| Return visit (30+ min) | 38 | $1,405 |
| Short return visit (20+ min) | 48 | $1,096 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 55 | $510 |
2019
| OFF/OP CNSLTJ NEW/EST MOD 40 | 28 | $2,686 |
| Short return visit (20+ min) | 29 | $611 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 48 | $556 |
2018
| CYSTOURETHROSCOPY | 12 | $805 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 93 | $787 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 19 | $509 |
Drugs they prescribed that Part D paid
$446,783
Pharmacies billed $446,783 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
956 generic and fewer than 11 brand-name prescriptions · $446,783 in drug cost · 183 antibiotic prescriptions to 92 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 344 | $249,608 | $726 |
| Gemtesa | 129 | $151,371 | $1,173 |
| Mirabegron Er | 15 | $9,828 | $655 |
| Methenamine Hippurate | 57 | $7,081 | $124 |
| Tamsulosin | 217 | $4,793 | $22 |
See all 17 drugs
| Myrbetriq | 344 | $249,608 | $726 |
| Gemtesa | 129 | $151,371 | $1,173 |
| Mirabegron Er | 15 | $9,828 | $655 |
| Methenamine Hippurate | 57 | $7,081 | $124 |
| Tamsulosin | 217 | $4,793 | $22 |
| Finasteride | 257 | $3,719 | $14 |
| Trospium Chloride | 80 | $2,699 | $34 |
| Estradiol | 26 | $1,806 | $69 |
| Dutasteride | 15 | $1,447 | $96 |
| Trimethoprim | 36 | $1,416 | $39 |
| Desmopressin Acetate | 13 | $894 | $69 |
| Alfuzosin Hcl Er | 31 | $808 | $26 |
| Cephalexin | 51 | $608 | $12 |
| Amoxicillin-Clavulanate Potass | 40 | $306 | $8 |
| Amitriptyline | 11 | $148 | $13 |
| Sildenafil Citrate | 12 | $87 | $7 |
| Ciprofloxacin | 11 | $67 | $6 |
Year by year
| 2024 | 1,494 | 448 | None | None | $446,783 |
| 2023 | 1,553 | 490 | None | None | $532,106 |
| 2022 | 1,624 | 507 | None | None | $466,799 |
| 2021 | 1,981 | 490 | 1% (11) | 37% | $526,769 |
| 2020 | 1,883 | 484 | None | 39% | $451,137 |
| 2019 | 1,476 | 393 | None | None | $300,343 |
| 2018 | 1,897 | 490 | None | None | $326,556 |
| 2017 | 1,915 | 514 | 1% (18) | None | $274,560 |
| 2016 | 1,823 | 449 | 1% (13) | None | $218,582 |
| 2015 | 1,878 | 452 | None | None | $199,480 |
| 2014 | 1,737 | 401 | 3% (51) | None | $149,559 |
| 2013 | 1,675 | 388 | 4% (63) | 25% | $141,833 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Myrbetriq | 474 | $376,889 | $795 |
| Gemtesa | 83 | $100,676 | $1,213 |
| Tamsulosin | 234 | $7,082 | $30 |
| Methenamine Hippurate | 37 | $5,951 | $161 |
| Premarin | 12 | $5,193 | $433 |
| Trospium Chloride | 75 | $5,006 | $67 |
| Finasteride | 225 | $3,075 | $14 |
| Desmopressin Acetate | 27 | $1,842 | $68 |
| Dutasteride | 28 | $1,445 | $52 |
| Trimethoprim | 24 | $1,292 | $54 |
| Alfuzosin Hcl Er | 31 | $1,090 | $35 |
| Nitrofurantoin | 22 | $850 | $39 |
| Cephalexin | 50 | $576 | $12 |
| Oxybutynin Chloride | 20 | $319 | $16 |
| Terazosin | 11 | $285 | $26 |
| Sildenafil Citrate | 14 | $109 | $8 |
| Sulfamethoxazole-Trimethoprim | 16 | $99 | $6 |
| Ciprofloxacin | 12 | $98 | $8 |
| Amoxicillin-Clavulanate Potass | 16 | $96 | $6 |
| Amoxicillin | 12 | $32 | $3 |
2022: 19 drugs
| Myrbetriq | 546 | $393,117 | $720 |
| Tolterodine Tartrate Er | 16 | $8,464 | $529 |
| Trospium Chloride | 99 | $7,770 | $78 |
| Premarin | 16 | $6,670 | $417 |
| Tamsulosin | 268 | $6,146 | $23 |
| Methenamine Hippurate | 25 | $5,423 | $217 |
| Finasteride | 219 | $5,017 | $23 |
| Desmopressin Acetate | 22 | $2,816 | $128 |
| Tadalafil | 13 | $2,584 | $199 |
| Estradiol | 26 | $2,374 | $91 |
| Nitrofurantoin | 27 | $1,777 | $66 |
| Oxybutynin Chloride Er | 12 | $1,420 | $118 |
| Cephalexin | 82 | $954 | $12 |
| Dutasteride | 13 | $772 | $59 |
| Alfuzosin Hcl Er | 35 | $761 | $22 |
| Nitrofurantoin Mono-Macro | 25 | $380 | $15 |
| Tobramycin Sulfate | 11 | $295 | $27 |
| Sulfamethoxazole-Trimethoprim | 15 | $214 | $14 |
| Amoxicillin-Clavulanate Potass | 19 | $191 | $10 |
2021: 22 drugs
| Myrbetriq | 625 | $447,437 | $716 |
| Tamsulosin | 361 | $8,313 | $23 |
| Methenamine Hippurate | 43 | $7,968 | $185 |
| Tolterodine Tartrate Er | 22 | $7,856 | $357 |
| Premarin | 19 | $7,754 | $408 |
| Trospium Chloride | 109 | $7,540 | $69 |
| Finasteride | 257 | $5,804 | $23 |
| Estradiol | 28 | $4,102 | $147 |
| Desmopressin Acetate | 36 | $3,733 | $104 |
| Nitrofurantoin | 38 | $2,483 | $65 |
| Oxybutynin Chloride Er | 27 | $1,574 | $58 |
| Cephalexin | 90 | $1,085 | $12 |
| Alfuzosin Hcl Er | 36 | $969 | $27 |
| Dutasteride | 18 | $922 | $51 |
| Gentamicin Sulfate | 16 | $904 | $56 |
| Nitrofurantoin Mono-Macro | 16 | $409 | $26 |
| Trimethoprim | 34 | $317 | $9 |
| Imipramine | 17 | $263 | $15 |
| Sulfamethoxazole-Trimethoprim | 27 | $260 | $10 |
| Amoxicillin | 15 | $162 | $11 |
| Amoxicillin-Clavulanate Potass | 15 | $133 | $9 |
| Sodium Chloride | 21 | $73 | $3 |
2020: 21 drugs
| Myrbetriq | 611 | $364,349 | $596 |
| Tolterodine Tartrate Er | 52 | $9,115 | $175 |
| Trospium Chloride | 77 | $8,543 | $111 |
| Methenamine Hippurate | 34 | $7,332 | $216 |
| Tamsulosin | 333 | $6,824 | $20 |
| Finasteride | 233 | $4,593 | $20 |
| Estradiol | 19 | $2,097 | $110 |
| Desmopressin Acetate | 21 | $2,032 | $97 |
| Nitrofurantoin | 29 | $1,957 | $67 |
| Oxybutynin Chloride Er | 27 | $1,595 | $59 |
| Gentamicin Sulfate | 14 | $1,312 | $94 |
| Solifenacin | 19 | $1,210 | $64 |
| Cephalexin | 91 | $1,143 | $13 |
| Nitrofurantoin Mono-Macro | 34 | $886 | $26 |
| Alfuzosin Hcl Er | 37 | $793 | $21 |
| Tadalafil | 11 | $771 | $70 |
| Dutasteride | 16 | $747 | $47 |
| Trimethoprim | 23 | $271 | $12 |
| Sulfamethoxazole-Trimethoprim | 40 | $259 | $6 |
| Amoxicillin | 13 | $100 | $8 |
| Sodium Chloride | 20 | $86 | $4 |
2019: 17 drugs
| Myrbetriq | 458 | $231,870 | $506 |
| Vesicare | 21 | $10,184 | $485 |
| Toviaz | 20 | $7,876 | $394 |
| Trospium Chloride | 65 | $6,664 | $103 |
| Tamsulosin | 269 | $5,648 | $21 |
| Finasteride | 140 | $2,960 | $21 |
| Methenamine Hippurate | 21 | $2,154 | $103 |
| Tolterodine Tartrate Er | 21 | $2,137 | $102 |
| Nitrofurantoin | 33 | $1,541 | $47 |
| Solifenacin | 18 | $1,377 | $76 |
| Nitrofurantoin Mono-Macro | 27 | $1,319 | $49 |
| Oxybutynin Chloride Er | 27 | $969 | $36 |
| Alfuzosin Hcl Er | 34 | $624 | $18 |
| Cephalexin | 73 | $611 | $8 |
| Sodium Chloride | 27 | $291 | $11 |
| Sulfamethoxazole-Trimethoprim | 43 | $247 | $6 |
| Ciprofloxacin | 16 | $108 | $7 |
2018: 24 drugs
| Myrbetriq | 459 | $210,281 | $458 |
| Vesicare | 77 | $31,763 | $413 |
| Elmiron | 11 | $12,689 | $1,154 |
| Toviaz | 32 | $11,669 | $365 |
| Premarin | 24 | $9,113 | $380 |
| Trospium Chloride | 94 | $9,031 | $96 |
| Tamsulosin | 348 | $8,030 | $23 |
| Tolterodine Tartrate Er | 36 | $4,805 | $133 |
| Nitrofurantoin | 68 | $2,933 | $43 |
| Neomycin-Polymyxin B | 13 | $2,635 | $203 |
| Finasteride | 149 | $2,175 | $15 |
| Oxybutynin Chloride Er | 35 | $1,594 | $46 |
| Cephalexin | 161 | $1,403 | $9 |
| Darifenacin Er | 11 | $1,402 | $127 |
| Methenamine Hippurate | 11 | $1,083 | $98 |
| Desmopressin Acetate | 12 | $936 | $78 |
| Alfuzosin Hcl Er | 38 | $913 | $24 |
| Nitrofurantoin Mono-Macro | 15 | $806 | $54 |
| Polyethylene Glycol 3350 | 22 | $583 | $26 |
| Sodium Chloride | 40 | $566 | $14 |
| Trimethoprim | 20 | $445 | $22 |
| Sulfamethoxazole-Trimethoprim | 68 | $373 | $5 |
| Doxazosin Mesylate | 13 | $160 | $12 |
| Ciprofloxacin | 20 | $92 | $5 |
2017: 22 drugs
| Myrbetriq | 336 | $132,650 | $395 |
| Vesicare | 121 | $44,694 | $369 |
| Trospium Chloride | 152 | $18,702 | $123 |
| Premarin | 22 | $8,234 | $374 |
| Tamsulosin | 277 | $8,126 | $29 |
| Estrace | 26 | $7,783 | $299 |
| Tolterodine Tartrate Er | 42 | $6,302 | $150 |
| Neomycin-Polymyxin B | 14 | $3,739 | $267 |
| Oxybutynin Chloride Er | 78 | $3,699 | $47 |
| Finasteride | 186 | $2,767 | $15 |
| Nitrofurantoin | 44 | $2,429 | $55 |
| Cephalexin | 172 | $2,278 | $13 |
| Desmopressin Acetate | 23 | $1,431 | $62 |
| Tolterodine | 11 | $1,313 | $119 |
| Dutasteride | 15 | $875 | $58 |
| Trimethoprim | 58 | $844 | $15 |
| Alfuzosin Hcl Er | 35 | $680 | $19 |
| Nitrofurantoin Mono-Macro | 21 | $594 | $28 |
| Polyethylene Glycol 3350 | 19 | $526 | $28 |
| Sodium Chloride | 34 | $355 | $10 |
| Sulfamethoxazole-Trimethoprim | 74 | $350 | $5 |
| Ciprofloxacin | 32 | $128 | $4 |
2016: 20 drugs
| Myrbetriq | 243 | $81,503 | $335 |
| Trospium Chloride | 174 | $22,422 | $129 |
| Elmiron | 27 | $20,991 | $777 |
| Vesicare | 40 | $20,881 | $522 |
| Premarin | 46 | $13,850 | $301 |
| Tamsulosin | 352 | $11,451 | $33 |
| Tolterodine Tartrate Er | 44 | $6,681 | $152 |
| Trospium Chloride Er | 32 | $5,661 | $177 |
| Oxybutynin Chloride Er | 159 | $5,599 | $35 |
| Dutasteride | 23 | $3,246 | $141 |
| Cephalexin | 104 | $2,157 | $21 |
| Finasteride | 141 | $1,915 | $14 |
| Nitrofurantoin | 45 | $1,454 | $32 |
| Trimethoprim | 56 | $872 | $16 |
| Gentamicin Sulfate | 20 | $603 | $30 |
| Tolterodine | 18 | $585 | $32 |
| Sulfamethoxazole-Trimethoprim | 91 | $577 | $6 |
| Nitrofurantoin Mono-Macro | 15 | $324 | $22 |
| Sodium Chloride | 28 | $314 | $11 |
| Ciprofloxacin | 27 | $218 | $8 |
2015: 24 drugs
| Myrbetriq | 167 | $50,233 | $301 |
| Vesicare | 98 | $30,918 | $315 |
| Trospium Chloride | 187 | $20,822 | $111 |
| Elmiron | 22 | $18,498 | $841 |
| Oxybutynin Chloride Er | 226 | $10,814 | $48 |
| Tolterodine Tartrate Er | 49 | $10,215 | $208 |
| Tamsulosin | 309 | $10,057 | $33 |
| Premarin | 38 | $9,490 | $250 |
| Trospium Chloride Er | 46 | $8,615 | $187 |
| Rapaflo | 24 | $4,614 | $192 |
| Nitrofurantoin | 57 | $1,689 | $30 |
| Finasteride | 76 | $1,004 | $13 |
| Bethanechol Chloride | 12 | $934 | $78 |
| Sodium Chloride | 50 | $814 | $16 |
| Desmopressin Acetate | 12 | $807 | $67 |
| Cephalexin | 107 | $790 | $7 |
| Sulfamethoxazole-Trimethoprim | 93 | $578 | $6 |
| Gentamicin Sulfate | 20 | $564 | $28 |
| Nitrofurantoin Mono-Macro | 24 | $551 | $23 |
| Ciprofloxacin | 57 | $266 | $5 |
| Trimethoprim | 21 | $224 | $11 |
| Imipramine | 27 | $203 | $8 |
| Sodium Chloride | 12 | $89 | $7 |
| Ampicillin Trihydrate | 17 | $74 | $4 |
2014: 27 drugs
| Vesicare | 112 | $31,431 | $281 |
| Myrbetriq | 61 | $17,984 | $295 |
| Elmiron | 14 | $14,262 | $1,019 |
| Trospium Chloride Er | 66 | $12,744 | $193 |
| Premarin | 45 | $9,677 | $215 |
| Trospium Chloride | 92 | $9,573 | $104 |
| Oxybutynin Chloride Er | 200 | $9,371 | $47 |
| Rapaflo | 27 | $6,328 | $234 |
| Tamsulosin | 280 | $5,670 | $20 |
| Enablex | 27 | $5,546 | $205 |
| Avodart | 18 | $4,964 | $276 |
| Finasteride | 121 | $2,092 | $17 |
| Nitrofurantoin | 51 | $1,991 | $39 |
| Desmopressin Acetate | 17 | $1,525 | $90 |
| Gentamicin Sulfate | 27 | $1,238 | $46 |
| Oxybutynin Chloride | 22 | $1,144 | $52 |
| Cephalexin | 133 | $962 | $7 |
| Bethanechol Chloride | 20 | $590 | $30 |
| Sulfamethoxazole-Trimethoprim | 69 | $452 | $7 |
| Nitrofurantoin Mono-Macro | 14 | $404 | $29 |
| Ciprofloxacin | 62 | $356 | $6 |
| Alfuzosin Hcl Er | 19 | $303 | $16 |
| Sodium Chloride | 30 | $288 | $10 |
| Trimethoprim | 28 | $286 | $10 |
| Hydrocodone-Acetaminophen | 32 | $285 | $9 |
| Imipramine | 35 | $250 | $7 |
| Ampicillin Trihydrate | 12 | $53 | $4 |
2013: 30 drugs
| Vesicare | 129 | $30,928 | $240 |
| Elmiron | 28 | $15,525 | $554 |
| Myrbetriq | 27 | $9,886 | $366 |
| Oxybutynin Chloride Er | 176 | $9,185 | $52 |
| Premarin | 47 | $8,826 | $188 |
| Avodart | 30 | $7,936 | $265 |
| Trospium Chloride | 58 | $6,863 | $118 |
| Trospium Chloride Er | 38 | $6,340 | $167 |
| Tamsulosin | 247 | $6,145 | $25 |
| Estrace | 33 | $4,958 | $150 |
| Enablex | 21 | $3,609 | $172 |
| Rapaflo | 21 | $3,304 | $157 |
| Finasteride | 124 | $2,896 | $23 |
| Detrol La | 14 | $2,835 | $202 |
| Sanctura Xr | 12 | $2,691 | $224 |
| Nitrofurantoin | 55 | $2,072 | $38 |
| Bethanechol Chloride | 18 | $1,052 | $58 |
| Alfuzosin | 36 | $902 | $25 |
| Sulfamethoxazole-Trimethoprim | 110 | $733 | $7 |
| Cephalexin | 89 | $732 | $8 |
| Imipramine | 43 | $479 | $11 |
| Nitrofurantoin Mono-Macro | 13 | $400 | $31 |
| Hydrocodone-Acetaminophen | 55 | $367 | $7 |
| Ciprofloxacin | 54 | $279 | $5 |
| Doxazosin Mesylate | 19 | $266 | $14 |
| Trimethoprim | 12 | $153 | $13 |
| Gentamicin Sulfate | 12 | $134 | $11 |
| Phenazopyridine | 13 | $101 | $8 |
| Sodium Chloride | 18 | $98 | $5 |
| Amitriptyline | 15 | $57 | $4 |
Money from drug and device companies
$3,877 in 2025
| 2025 | 6 | 15 | $3,395 | $3,877 |
| 2024 | 8 | 19 | $6,800 | $8,125 |
| 2023 | 6 | 27 | $3,422 | $14,299 |
| 2022 | 6 | 19 | $20,050 | $20,487 |
| 2021 | 3 | 4 | $5,113 | $5,204 |
| 2020 | 5 | 5 | $1,213 | $1,410 |
| 2019 | 7 | 13 | $2,514 | $4,097 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Saluda Medical Americas | Evoke | $2,750 | 4 payments
|
| Coloplast | Altis | $717 | 3 payments
|
| Bluewind Medical | Revi | $216 | 5 payments
|
| Boston Scientific | General - Erectile Dysfunction | $146 | 1 payment
|
| Medtronic | Eea | $30 | 1 payment
|
| Ambu | None | $18 | 1 payment
|
See all 15 published payments
| Coloplast | Meals · 2025-12-04 | Altis | $30 |
| Saluda Medical Americas | Consulting · 2025-11-26 | Evoke | $500 |
| Coloplast | Meals · 2025-11-03 | Altis | $72 |
| Boston Scientific | Meals · 2025-10-31 | General - Erectile Dysfunction | $146 |
| Bluewind Medical | Meals · 2025-10-24 | Revi | $19 |
| Saluda Medical Americas | Consulting · 2025-09-10 | Evoke | $750 |
| Bluewind Medical | Meals · 2025-07-03 | Revi | $22 |
| Bluewind Medical | Meals · 2025-06-13 | Revi | $25 |
| Bluewind Medical | Meals · 2025-06-13 | Revi | $4 |
| Saluda Medical Americas | Consulting · 2025-05-23 | Evoke | $750 |
| Bluewind Medical | Meals · 2025-04-29 | Revi | $147 |
| Saluda Medical Americas | Consulting · 2025-03-26 | Evoke | $750 |
| Medtronic | Consulting · 2025-03-24 | Eea | $30 |
| Coloplast | Consulting · 2025-02-14 | None | $615 |
| Ambu | Meals · 2025-01-27 | None | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $8,125
| PROCEPT BioRobotics | Aquabeam System | $6,824 | 6 payments
|
| Coloplast | Titan | $805 | 4 payments
|
| Bluewind Medical | Revi | $150 | 1 payment
|
| Axonics | Axonics | $143 | 4 payments
|
| Uromedica | Proact | $103 | 1 payment
|
| Medtronic | Interstim | $49 | 1 payment
|
| Boston Scientific | Solyx Sis System | $41 | 1 payment
|
| Valencia Technologies | Ecoin Device Kit | $10 | 1 payment
|
2023: $14,299
| Coloplast | Altis | $10,670 | 11 payments
|
| Boston Scientific | Rezum Generator | $1,800 | 8 payments
|
| PROCEPT BioRobotics | Aquabeam Robotic System | $628 | 5 payments
|
| Axonics | Axonics | $625 | 1 payment
|
| Endo Pharmaceuticals | None | $499 | 1 payment
|
| Teleflex | Urolift | $78 | 1 payment
|
2022: $20,487
| PROCEPT BioRobotics | Aquabeam Robotic System | $16,174 | 14 payments
|
| Saluda Medical Americas | Evoke Scs | $2,375 | 1 payment
|
| Boston Scientific | Clinical Trial Product | $1,575 | 1 payment
|
| C. R. Bard Inc. & Subsidiaries | None | $147 | 1 payment
|
| Ambu | None | $111 | 1 payment
|
| Medtronic | Interstim | $106 | 1 payment
|
2021: $5,204
| PROCEPT BioRobotics | Aquabeam Robotic System | $3,013 | 2 payments
|
| Shionogi | None | $2,100 | 1 payment
|
| Medtronic | Interstim | $92 | 1 payment
|
2020: $1,410
| Axonics Modulation Technologies | Axonics R-Snm System | $1,000 | 1 payment
|
| C. R. Bard Inc. & Subsidiaries | None | $213 | 1 payment
|
| Medtronic USA | Interstim | $104 | 1 payment
|
| Boston Scientific | General - Therapies | $78 | 1 payment
|
| 180 Medical | Speedicath | $14 | 1 payment
|
2019: $4,097
| Ferring Pharmaceuticals | Nocdurna | $1,950 | 1 payment
|
| Boston Scientific | General Bph | $1,149 | 6 payments
|
| Allergan | Botox | $510 | 2 payments
|
| Covidien LP | None | $190 | 1 payment
|
| Medtronic USA | Interstim | $141 | 1 payment
|
| Coloplast | Altis | $96 | 1 payment
|
| Olympus America | Olympus Laser Devices | $62 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| COLOPLAST CORP · Eukelade · 2024 | This clinician | $15,329 |
| COLOPLAST CORP · No Study · 2023 | This clinician | $5,215 |
| Axonics Modulation Technologies, Inc. · Artisan · 2020 | Their institution | $3,484 |
| Axonics, Inc. · Artisan · 2021 | Their institution | $2,960 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1780657171
- Licence
- CA G84429California G84429: Current · expires 2027-09-30
- Trained
- Harvard Medical School, 1992
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X); Federal specialty code 2088F0040X (2088F0040X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-02-08
- NPI last updated
- 2024-03-13
- NPI record certified
- 2024-03-13
This is when the NPI record was last certified, not a medical board exam.